Research Journal of Pharmaceutical Dosage Form and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Formulation and Evaluation of Chewable Oral Jelly containing Zolmitriptan hydrochloride


Affiliations
1 Department of Pharmaceutics, Institute of Pharmacy, Ankara,, Turkey
     

   Subscribe/Renew Journal


The present study aimed to develop an immediate release of Zolmitriptan hydrochloride oral jellies for the treatment of severe migraine. The jellies were prepared by using chitosan hydrochloride with different concentration as a polymer and propylene glycol as a co-polymer. The prepared jellies were evaluated for its various physio-chemical parameters such as pH, appearance, viscosity, in vitro drug release and drug content. The pH of the prepared formulations was found to be in the range of 7.5-8.1. The appearance of the prepared formulations was transparent to opaque. The viscosity of the prepared jellies was found to be in the range of 273600 - 542335 CPS. The drug content of the prepared jellies was found to be more than 97%. The in vitro drug release immediate release with increased concentration of Chitosan Hydrochloride, and the drug releasewere found to be more than 60% in 15 minutes. This present studies concluded that Zolmitriptan hydrochloride oral jellies can be a better alternative for oral dispersible tablets and it could produce improved bioavailability as compared to other fast releasing dosage form. From the above studies of various parameters, it was concluded that the FJ5 formulation was found to be optimized formulation.

Keywords

Oral Jelly, Migraine, Zolmitriptan Hydrochloride, Chitosan Hydrochloride.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Aminoff, Roger P. Simon, David A. Greenberg, Michael J. Clinical neurology (7 ed.). New York, N.Y: Lange Medical Books/McGraw-Hill. (2009) pp. 85–88.

  • Malviya VR, Pande SD, Road CKN. Preparation ad Evaluation of Zolmitriptan Hydrochloride Lozenge. J Pharma Res. 2019;8(8):624-629.

  • Malviya VR, Tawar MG. Preparation and Evaluation of Oral Dispersible Strips of Teneligliptin Hydrobromide for Treatment of Diabetes Mellitus. International Journal of Pharmaceutical Sciences and Nanotechnology. 2020 Jan 31;13(1):4745-52.

  • Raja Manali M, Dhiren P, Oral medicated jelly: a recent advancement in formulation, An International Journal of Pharmaceutical Sciences, 2016; 7(2):13-20.

  • Malviya V, Thakur Y, Gudadhe SS, Tawar M. Formulation and evaluation of natural gum based fast dissolving tablet of Meclizine hydrochloride by using 3 factorial design 2. Asian Journal of Pharmacy and Pharmacology. 2020;6(2):94-100.

  • Raut S, Uplanchiwar V, Bhadoria S, Gahane A, Jain SK, Patil S. Comparative evaluation of zidovudine loaded hydrogels and emulgels. Research Journal of Pharmacy and Technology. 2012;5(1):41-5.

  • Malviya VR, Pande SD, Bobade NN. Preparation and Evaluation of Sustained Release Beads of Zolmitriptan Hydrochloride. Research Journal of Pharmacy and Technology. 2019;12(12):5972-6.

  • Kumar L. An Overview on Preparation and Evaluation of Microparticulated Intra-Vaginal Gel. Research Journal of Pharmacy and Technology. 2009;2(1):48-51.

  • Shah RR, Magdum CS, Wadkar KA, Naikwade NS. Fluconazole topical microemulsion: preparation and evaluation. Research Journal of Pharmacy and Technology. 2009;2(2):353-7.

  • Shete AS, Mohite VL, Yadav AV. Preparation and Evaluation of Mucilage of Ocimum Basilicum as a Gelling Agent. Research Journal of Pharmacy and Technology. 2008;1(3):201-3.

  • Yadav AV, Urade MN. Preparation and evaluation of chitosan containing mucoadhesive buccal films of venlafaxine hydrochloride. Research Journal of Pharmacy and Technology. 2010;3(4):1213-7.

  • Begum SA, Sree VP, Anusha V, Veronica ZK, Sree PV, Prameela K, Nazeema MD, Padmalatha K. Formulation and evaluation of pediatric oral soft jellies of salbutamol sulphate. Research Journal of Pharmacy and Technology. 2018;11(11):4939-45.

  • Charyulu RN, Devi PP, Jose J, Shetty AV. Formulation and evaluation of mucoadhesive oral gel containing miconazole nitrate for oral candidiasis. Research Journal of Pharmacy and Technology. 2013;6(11):1251-7.

  • Kumar R, Jose J, Mahin MM, Raut R, Masurkar S, Swamy VB. Formulation and Evaluation of Gels from Gum of Cissus refescence. Research Journal of Pharmacy and Technology. 2012;5(3):415-23.

  • Malviya V, Manekar S. Design, Development and Evaluation of Aceclofenac and Curcumin Agglomerates by Crystallo CoAgglomeration Technique. Research Journal of Pharmacy and Technology. 2021 Mar 1;14(3):1535-41.

  • Malviya V. Preparation and Evaluation of Emulsomes as a Drug Delivery System for Bifonazole. Indian Journal of Pharmaceutical Education and Research. 2021 Jan 1;55(1):86-94.

  • Singh S. Drug Stability Testing and Shelf-life Determination According to International Guidelines. Pharm. Technol. 1999; 23:68-88

  • Singh S, Bakshi M. Development of stability-indicating assay methods-A critical review. J. Pharm. Biomed. Anal. 2002; 28:1011-1040.

  • Malviya V, Pande S. Development and Evaluation of Fast dissolving Film of Fluoxetine hydrochloride. Research Journal of Pharmacy and Technology. 2021 Oct 31;14(10):5345-50.

  • Malviya V, Ladhake V, Gajbiye K, Satao J, Tawar M. Design and Characterization of Phase Transition System of Zolmitriptan Hydrochloride for Nasal Drug Delivery System. International Journal of Pharmaceutical Sciences and Nanotechnology. 2020 May 31;13(3):4942-51.


Abstract Views: 149

PDF Views: 0




  • Formulation and Evaluation of Chewable Oral Jelly containing Zolmitriptan hydrochloride

Abstract Views: 149  |  PDF Views: 0

Authors

Wajid Ahmad
Department of Pharmaceutics, Institute of Pharmacy, Ankara,, Turkey
Rihan Jawed
Department of Pharmaceutics, Institute of Pharmacy, Ankara,, Turkey

Abstract


The present study aimed to develop an immediate release of Zolmitriptan hydrochloride oral jellies for the treatment of severe migraine. The jellies were prepared by using chitosan hydrochloride with different concentration as a polymer and propylene glycol as a co-polymer. The prepared jellies were evaluated for its various physio-chemical parameters such as pH, appearance, viscosity, in vitro drug release and drug content. The pH of the prepared formulations was found to be in the range of 7.5-8.1. The appearance of the prepared formulations was transparent to opaque. The viscosity of the prepared jellies was found to be in the range of 273600 - 542335 CPS. The drug content of the prepared jellies was found to be more than 97%. The in vitro drug release immediate release with increased concentration of Chitosan Hydrochloride, and the drug releasewere found to be more than 60% in 15 minutes. This present studies concluded that Zolmitriptan hydrochloride oral jellies can be a better alternative for oral dispersible tablets and it could produce improved bioavailability as compared to other fast releasing dosage form. From the above studies of various parameters, it was concluded that the FJ5 formulation was found to be optimized formulation.

Keywords


Oral Jelly, Migraine, Zolmitriptan Hydrochloride, Chitosan Hydrochloride.

References